Straus, D J <br/><br/>
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jul 1990 
 - 1173-86 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1990.8.7.1173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Dacarbazine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hematocrit<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lomustine--administration & dosage<br/>Lymphatic Metastasis<br/>Male<br/>Mechlorethamine--administration & dosage<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Models, Biological<br/>Neoplasm Staging<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Prognosis<br/>Remission Induction<br/>Survival Analysis<br/>Vinblastine--administration & dosage<br/>Vincristine--administration & dosage<br/>Vindesine--administration & dosage